We are excited about working hand-in-hand with Cyanta. They have a great business development team and excellent technical team. Their analytical excellence and commitment to quality and our knowledge of the regulatory process make this a great relationship for us and our clients.
Maryland Heights, MO (Vocus) September 30, 2010
Cyanta Analytical Services, an analytical service provider to the pharmaceutical and medical device industry, and Global BioDevelopment, a consulting firm for life science companies, have finalized a business agreement in which each organization would share sales, marketing, and technical capabilities to help grow each other’s business. Cyanta will utilize its sales and marketing team to promote the capabilities of the relationship while Global BioDevelopment will leverage its diverse industry connections to support the partnership.
The analytical services and medical device testing will be performed at Cyanta which operates cGMP/GLP facilities in St. Louis, MO. Global BioDevelopment will provide in-depth regulatory support to clients regarding FDA requirements and will assist with designing comprehensive programs which efficiently help clients achieve their development goals. By combining Global BioDevelopment’s know-how of the FDA drug development process and Cyanta’s analytical expertise, clients can be assured they are receiving industry leading quality service that will expedite their drug development program.
Dave Riggs was excited about the new business relationship. “Mike Lewandowski and the team at Global BioDevelopment have a superior understanding of the full medical device and pharmaceutical development process. Combine Mike’s 10,000 foot view with our excellent project execution and customer service and you have a really powerful solution to offer clients."
Mr. Lewandowski echoed Mr. Riggs sentiments, “We are excited about working hand-in-hand with Cyanta. They have a great business development team and excellent technical team. Their analytical excellence and commitment to quality and our knowledge of the regulatory process make this a great relationship for us and our clients.”
The partnership expects to generate interest among early phase small and virtual organizations which need additional support to manage their pre-IND programs. These organizations often look to contract laboratories like Cyanta and consultants like Global BioDevelopment to manage preclinical programs and perform activities like custom synthesis, method development, method validation, bioanalysis and drug substance characterization.
About Cyanta Analytical Services
Cyanta Analytical Services provides comprehensive analytical, custom synthesis and bioanalytical development services for the pharmaceutical, biotech and medical device industry. Our services support early to late phase projects and include analytical method development/validation, reference standard characterization, impurity profiles, contaminant studies, stability services, extractables/leachables studies and analytical support for formulations. For more information visit http://www.cyanta.com.
About Global BioDevelopment
Global BioDevelopment is a pharmaceutical development and consulting company. From concept through regulatory submission and clinical studies GlobalBDI designs, implements and manages the entire development program. For more information, visit http://www.globalbdi.com.
Phone: (314) 291-6620